SCP
CELG

Syntal Capital Partners’s Celgene Corp CELG Stock Holding History

Syntal Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,800
Closed -$351K – 298
2019
Q2 		$351K Hold
3,800
– – 0.08% 189
2019
Q1 		$358K Hold
3,800
– – 0.16% 93
2018
Q4 		$243K Hold
3,800
– – 0.15% 80
2018
Q3 		$340K Hold
3,800
– – 0.12% 123
2018
Q2 		$301K Hold
3,800
– – 0.11% 119
2018
Q1 		$338K Sell
3,800
-100
-3% -$9.6K 0.12% 112
2017
Q4 		$407K Buy
+3,900
New +$440K 0.12% 110
2017
Q2 		– Sell
-2,702
Closed -$336K – 122
2017
Q1 		$336K Buy
2,702
+474
+21% +$56.7K 0.28% 70
2016
Q4 		$257K Buy
+2,228
New +$248K 0.24% 95

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Syntal Capital Partners's CELG Position: Q3 2019 in Review

Syntal Capital Partners sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 3,800 shares — an estimated $351K sold.

Syntal Capital Partners first reported a position in CELG in Q4 2016 and held it in 9 quarters. The position peaked at $407K in Q4 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Syntal Capital Partners reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Syntal Capital Partners sold 3,800 Celgene Corp shares in Q3 2019, an estimated $351K.
  • Syntal Capital Partners first reported a position in Celgene Corp in Q4 2016 and held it in 9 quarters.
  • Syntal Capital Partners's Celgene Corp position peaked at $407K in Q4 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Syntal Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.